Neuronetics, Inc.

NasdaqGM STIM

Neuronetics, Inc. Market Capitalization on January 14, 2025: USD 120.21 M

Neuronetics, Inc. Market Capitalization is USD 120.21 M on January 14, 2025, a 35.60% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Neuronetics, Inc. 52-week high Market Capitalization is USD 142.14 M on April 01, 2024, which is 18.24% above the current Market Capitalization.
Neuronetics, Inc. 52-week low Market Capitalization is USD 18.50 M on November 13, 2024, which is -84.61% below the current Market Capitalization.
Neuronetics, Inc. average Market Capitalization for the last 52 weeks is USD 66.78 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NasdaqGM: STIM

Neuronetics, Inc.

CEO	Mr. Keith J. Sullivan
IPO Date	June 28, 2018
Location	United States
Headquarters	3222 Phoenixville Pike
Employees	203
Sector	Health Care
Industries Pharmaceuticals Telehealth

Description

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Key trends

Past 5 years